Clinical Trials Browser

Phase 2 × INDUSTRY × Docosahexaenoic Acids × Clear all

NCT00244816 2025-10-23

Taxoprexin® Treatment for Advanced Eye Melanoma

Phase 2 Completed

Melanoma

NCT00422877 2025-10-16

Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary Tract

Phase 2 Terminated

Gastrointestinal

Liver Neoplasms

NCT00249262 2025-09-26

Taxoprexin Treatment for Advanced Skin Melanoma

Phase 2 Completed

Melanoma